Antimicrobial Agents Practice Questions

Q: What is the drug of choice for treating Chlamydia trachomatis infection during pregnancy?

Amoxicillin. **Explanation:** The drug of choice for *Chlamydia trachomatis* infection in pregnancy has traditionally been **Azithromycin** (1g single dose). However, according to current guidelines (including CDC and WHO), **Amoxicillin (500 mg TID for 7 days)** is a preferred first-line alternative and is the correct answer among the provided options. **1. Why Amoxicillin is Correct:** Amoxicillin is highly effective against *Chlamydia* in the pregnant population. It is a **Category B** drug, meaning it is safe for both the mother and the fetus. While beta-lactams are generally not used for Chlamydia in non-pregnant adults (due to the organism being intracellular), Amoxicillin shows excellent clinical cure rates in pregnant women and lacks the fetal risks associated with other antibiotics. **2. Why Other Options are Incorrect:** * **Metronidazole:** Primarily used for anaerobic infections and *Trichomonas vaginalis*; it is not effective against *Chlamydia*. * **Cefazolin:** A first-generation cephalosporin used mainly for surgical prophylaxis and Gram-positive skin infections; it has no activity against *Chlamydia*. * **Clindamycin:** Used for Bacterial Vaginosis or Pelvic Inflammatory Disease (in combination), but it is not a primary treatment for uncomplicated Chlamydial cervicitis. **3. High-Yield NEET-PG Pearls:** * **Contraindication:** **Doxycycline** (the DOC for non-pregnant adults) is strictly **contraindicated** in pregnancy (Category D) because it causes fetal teeth discoloration and bone growth inhibition. * **Standard DOC:** If Azithromycin is an option, it is usually the top choice due to single-dose compliance. If absent, Amoxicillin is the next best answer. * **Erythromycin:** Previously used but now avoided due to high gastrointestinal side effects. * **Neonatal Complication:** Untreated maternal Chlamydia can lead to **Neonatal Conjunctivitis** (5–12 days post-birth) and **Infantile Pneumonia**.

Q: Tetracycline chelates with which of the following?

All of the above. **Explanation:** The correct answer is **D. All of the above.** Tetracyclines are bacteriostatic antibiotics that possess a unique chemical structure containing multiple hydroxyl and carbonyl groups. This structure allows them to act as **chelating agents**, meaning they readily bind to **multivalent metal cations** such as Calcium ($Ca^{2+}$), Magnesium ($Mg^{2+}$), Aluminum ($Al^{3+}$), Iron ($Fe^{2+/3+}$), and Zinc ($Zn^{2+}$). When tetracyclines form these insoluble chelates, their gastrointestinal absorption is significantly impaired. This is why patients are advised not to take tetracyclines with milk (rich in Calcium), antacids (containing Magnesium or Aluminum), or iron supplements. **Analysis of Options:** * **A, B, and C:** Each of these is correct individually. Calcium (found in dairy), Magnesium, and Aluminum (found in common antacids) all form stable, non-absorbable complexes with tetracyclines in the gut. Since all three interfere with the drug's bioavailability, "All of the above" is the most accurate choice. **High-Yield Clinical Pearls for NEET-PG:** 1. **Teeth and Bones:** Tetracycline’s affinity for **Calcium** leads to its deposition in growing teeth and bones. This causes permanent **yellowish-brown discoloration** of teeth and enamel hypoplasia; hence, it is contraindicated in pregnancy and children under 8 years of age. 2. **Drug Interactions:** Always counsel patients to maintain a gap of at least 2 hours between tetracycline administration and the intake of dairy products or antacids. 3. **Exception:** **Doxycycline and Minocycline** are less affected by food and milk compared to older tetracyclines, though they still chelate with iron and antacids. 4. **Fanconi Syndrome:** Use of **outdated (expired) tetracyclines** can lead to proximal renal tubular acidosis (Fanconi Syndrome) due to degradation products like epitetracycline.

Q: Which of the following statements about carboxypenicillins is false?

Nephrotoxic. **Explanation:** Carboxypenicillins (e.g., **Ticarcillin** and **Carbenicillin**) are extended-spectrum penicillins primarily used for their activity against Gram-negative bacilli. **1. Why Option A is False (The Correct Answer):** Carboxypenicillins are **not typically nephrotoxic**. While they are excreted renally, they do not cause direct tubular damage like aminoglycosides or amphotericin B. Their primary electrolyte-related side effect is **hypokalemia** and **hypernatremia** (due to the high sodium content in the parenteral formulations), rather than renal failure. **2. Analysis of Other Options:** * **Option B (Sensitive to penicillinase):** This is **true**. Carboxypenicillins are easily degraded by staphylococcal beta-lactamases (penicillinase). Therefore, they are often combined with beta-lactamase inhibitors like Clavulanic acid (e.g., Ticar-Clav). * **Option C (Effective against Pseudomonas):** This is **true**. Their defining clinical feature is activity against *Pseudomonas aeruginosa*, though they are less potent than Ureidopenicillins (Piperacillin). * **Option D (Platelet aggregation affected):** This is **true**. Carboxypenicillins can interfere with platelet aggregation by binding to the platelet surface or ADP receptors, leading to an increased bleeding time (though platelet count remains normal). **High-Yield Clinical Pearls for NEET-PG:** * **Sodium Load:** Carbenicillin contains high amounts of sodium (~4.7 mEq/g), which can precipitate **Congestive Heart Failure (CHF)** or edema in susceptible patients. * **Ureidopenicillins vs. Carboxypenicillins:** Piperacillin (a Ureidopenicillin) is generally preferred over Ticarcillin because it has superior anti-pseudomonal activity and lower sodium content. * **Bleeding Risk:** Always monitor bleeding time in patients on high-dose Carbenicillin/Ticarcillin, especially if they are on anticoagulants.

Q: Which of the following fluoroquinolones does not require dose adjustment in a patient with creatinine clearance of < 50 mL/min?

Trovafloxacin. **Explanation:** The correct answer is **Trovafloxacin**. **1. Why Trovafloxacin is correct:** Most fluoroquinolones are primarily eliminated by the kidneys via glomerular filtration and active tubular secretion. Therefore, their dosage must be adjusted in patients with renal impairment (CrCl < 50 mL/min) to prevent toxicity. However, **Trovafloxacin** and **Moxifloxacin** are exceptions. Trovafloxacin is primarily metabolized by the liver and excreted through the bile/feces. Because its clearance is independent of renal function, no dose adjustment is required in patients with renal failure. **2. Why the other options are incorrect:** * **Ciprofloxacin (Option A):** It is the prototype fluoroquinolone and is predominantly excreted unchanged in the urine. It requires significant dose reduction in renal impairment. * **Lomefloxacin (Option C) & Sparfloxacin (Option D):** These are long-acting fluoroquinolones. Lomefloxacin is excreted almost entirely by the kidneys, and Sparfloxacin, while having some biliary excretion, still relies significantly on renal clearance. Both require dose adjustments when CrCl drops below 50 mL/min. **3. NEET-PG High-Yield Clinical Pearls:** * **Mnemonic for Hepatic Clearance:** Remember **"M-T"** (Moxifloxacin and Trovafloxacin) as the fluoroquinolones that are "Safe for the Kidney" (Hepatic elimination). * **Moxifloxacin** is the most frequently tested drug in this category for NEET-PG. It is also known as a "Respiratory Quinolone." * **Trovafloxacin Warning:** Although it doesn't require renal adjustment, its clinical use is severely restricted due to the risk of **severe hepatotoxicity** (liver failure). * **Pefloxacin** is another fluoroquinolone that is primarily metabolized by the liver.

Q: Quinolones are not effective in the treatment of which of the following?

Treponema. **Explanation:** The correct answer is **Treponema (Option B)**. **1. Why Treponema is the Correct Answer:** Quinolones (and Fluoroquinolones) act by inhibiting **DNA Gyrase** (Topoisomerase II) and **Topoisomerase IV**, enzymes essential for bacterial DNA replication. However, *Treponema pallidum* (the causative agent of Syphilis) is naturally resistant to fluoroquinolones. The primary treatment for Syphilis remains **Penicillin G**. Quinolones lack sufficient clinical efficacy against most spirochetes, making them ineffective for treating syphilis. **2. Why the other options are incorrect:** * **Mycobacteria (Option A):** Fluoroquinolones like Levofloxacin and Moxifloxacin are potent "second-line" anti-tubercular drugs. They are highly effective against *M. tuberculosis* and *M. leprae*. * **Haemophilus (Option C):** *Haemophilus influenzae* is highly sensitive to second and third-generation fluoroquinolones. They are frequently used to treat respiratory tract infections caused by this organism. * **Salmonella (Option D):** Fluoroquinolones (specifically Ciprofloxacin and Ceftriaxone) have traditionally been the drugs of choice for Enteric fever (Typhoid) caused by *Salmonella typhi*, though resistance is increasing (NALC - Nalidixic acid resistant strains). **Clinical Pearls for NEET-PG:** * **Respiratory Quinolones:** Levofloxacin, Moxifloxacin, and Gemifloxacin (enhanced activity against *S. pneumoniae*). * **Anti-pseudomonal Quinolones:** Ciprofloxacin and Pefloxacin. * **Mechanism of Resistance:** Most commonly due to mutations in the *gyrA* or *parC* genes or through Qnr proteins (plasmid-mediated). * **Key Side Effects:** Tendon rupture (Achilles tendon), QT prolongation, and contraindication in pregnancy/children due to cartilage toxicity.

Q: Adverse effects of isoniazid (INH) are all EXCEPT?

Hypothermia. **Explanation:** Isoniazid (INH) is a primary bactericidal drug used in the treatment of Tuberculosis. The correct answer is **Hypothermia**, as INH is actually associated with **drug-induced fever** (a hypersensitivity reaction), not a decrease in body temperature. **Analysis of Options:** * **Peripheral Neuritis (Option A):** This is the most common neurological side effect. INH interferes with pyridoxine (Vitamin B6) metabolism by inhibiting pyridoxine phosphokinase and increasing its renal excretion. This leads to a deficiency, resulting in paresthesia. It is prevented by co-administering **10–50 mg/day of Pyridoxine**. * **Hepatitis (Option B):** Hepatotoxicity is the most serious side effect of INH. It is caused by the metabolite **monoacetylhydrazine**. The risk increases with age, alcohol consumption, and in "fast acetylators" (though this is debated, fast acetylators produce the toxic metabolite more rapidly). * **Acne (Option D):** INH is a well-known cause of **drug-induced acneiform eruptions**. These typically appear as monomorphic pustules or papules on the trunk and arms, often lacking comedones. **High-Yield Clinical Pearls for NEET-PG:** 1. **Metabolism:** INH is metabolized via **Acetylation**. Genetic polymorphism (Slow vs. Fast acetylators) determines the half-life and toxicity profile. 2. **Sideroblastic Anemia:** INH can cause this due to interference with heme synthesis (which requires B6). 3. **Drug Interactions:** INH is a potent **Cytochrome P450 inhibitor**, increasing levels of phenytoin and carbamazepine. 4. **Systemic Lupus Erythematosus (SLE):** INH is a classic cause of **Drug-induced Lupus** (Anti-histone antibodies positive).

Q: Trimethoprim acts by:

Inhibiting dihydrofolate reductase enzyme. ### Explanation **Correct Answer: B. Inhibiting dihydrofolate reductase enzyme** Trimethoprim is a synthetic antibiotic that interferes with bacterial folic acid synthesis. Bacteria cannot absorb preformed folic acid and must synthesize it de novo. Trimethoprim acts on the second step of this pathway by binding to and inhibiting the enzyme **dihydrofolate reductase (DHFR)**. This prevents the conversion of dihydrofolic acid to tetrahydrofolic acid (the active form), ultimately halting DNA synthesis and bacterial growth. **Analysis of Incorrect Options:** * **Option A & D:** These describe the mechanism of action for protein synthesis inhibitors. **Peptidyl transferase** is inhibited by **Chloramphenicol**, while binding to the **50S ribosomal subunit** is characteristic of Macrolides (e.g., Erythromycin), Clindamycin, and Linezolid. * **Option C:** **Dihydropteroate synthase** is the enzyme inhibited by **Sulfonamides**. Sulfonamides act on the first step of the folate pathway by competing with PABA (Para-aminobenzoic acid). **High-Yield Clinical Pearls for NEET-PG:** * **Cotrimoxazole:** This is a fixed-dose combination of **Sulfamethoxazole and Trimethoprim** in a **5:1 ratio**. This combination results in a **sequential blockade** of folate synthesis, making the effect bactericidal rather than bacteriostatic. * **Selectivity:** Trimethoprim has a much higher affinity (approx. 50,000 to 100,000 times) for bacterial DHFR than human DHFR, which accounts for its therapeutic safety. * **Pyrimethamine:** A related DHFR inhibitor used primarily for Malaria and Toxoplasmosis. * **Methotrexate:** A human DHFR inhibitor used as an anticancer and immunosuppressant drug. * **Side Effects:** Long-term use of Trimethoprim can lead to **megaloblastic anemia**, leukopenia, and granulocytopenia due to folate deficiency.

Q: What is the first-line drug for prophylaxis of pneumocystosis?

TMP-SMX. **Explanation:** **Pneumocystis jirovecii pneumonia (PCP)** is a significant opportunistic infection in immunocompromised patients, particularly those with HIV/AIDS (CD4 count <200 cells/mm³). **1. Why TMP-SMX is the Correct Answer:** **Trimethoprim-Sulfamethoxazole (TMP-SMX)**, also known as Co-trimoxazole, is the **first-line drug** for both the treatment and prophylaxis of pneumocystosis. It works by inhibiting sequential steps in the folic acid synthesis pathway of the fungus. It is preferred due to its high efficacy, low cost, and simultaneous protection against other pathogens like *Toxoplasma gondii* and certain bacterial respiratory infections. **2. Why Other Options are Incorrect:** * **B. Dapsone:** This is a **second-line** alternative for patients who are intolerant to TMP-SMX. It is less effective and requires screening for G6PD deficiency to avoid hemolytic anemia. * **C. Pyrimethamine:** While it also inhibits folic acid synthesis, it is primarily used in combination with Sulfadiazine for the treatment of **Toxoplasmosis**, not as a monotherapy or first-line agent for PCP. * **D. Atovaquone:** This is an alternative prophylactic agent used only when patients cannot tolerate both TMP-SMX and Dapsone. It is expensive and generally less effective than TMP-SMX. **High-Yield Clinical Pearls for NEET-PG:** * **Prophylaxis Indication:** Start in HIV patients when **CD4 count 35 mmHg) to prevent inflammation-induced respiratory failure. * **Alternative for severe cases:** IV Pentamidine (monitor for hypoglycemia and nephrotoxicity).

Question 1

What is the drug of choice for treating Chlamydia trachomatis infection during pregnancy?

Accepted Answer

Amoxicillin

Answer

Metronidazole

Answer

Cefazolin

Answer

Clindamycin

Question 2

Tetracycline chelates with which of the following?

Accepted Answer

All of the above

Answer

Calcium salts

Answer

Magnesium salts

Answer

Aluminum salts

Question 3

Which of the following statements about carboxypenicillins is false?

Accepted Answer

Nephrotoxic

Answer

Sensitive to penicillinase

Answer

Effective against Pseudomonas

Answer

Platelet aggregation affected

Question 4

Which of the following fluoroquinolones does not require dose adjustment in a patient with creatinine clearance of < 50 mL/min?

Accepted Answer

Trovafloxacin

Answer

Ciprofloxacin

Answer

Lomefloxacin

Answer

Sparfloxacin

Question 5

Which of the following drugs is NOT used in the treatment of Taenia solium infection?

Accepted Answer

Niclosamide

Answer

Praziquantel

Answer

Albendazole

Answer

Flubendazole

Question 6

Which drug does not show an "after-treatment" reaction?

Accepted Answer

Isoniazid (INH)

Answer

Beta lactams

Answer

Ciprofloxacin

Answer

Gentamycin

Question 7

Quinolones are not effective in the treatment of which of the following?

Accepted Answer

Treponema

Answer

Mycobacteria

Answer

Haemophilus

Answer

Salmonella

Question 8

Adverse effects of isoniazid (INH) are all EXCEPT?

Accepted Answer

Hypothermia

Answer

Peripheral neuritis

Answer

Hepatitis

Answer

Acne

Question 9

Trimethoprim acts by:

Accepted Answer

Inhibiting dihydrofolate reductase enzyme

Answer

Inhibiting peptidyl transferase enzyme

Answer

Inhibiting Dihydropteroate synthase enzyme

Answer

Binding to the 50s ribosomal unit and preventing protein synthesis

Question 10

What is the first-line drug for prophylaxis of pneumocystosis?

Accepted Answer

TMP-SMX

Answer

Dapsone

Answer

Pyrimethamine

Answer

Atovaquone

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?